Knobbe Martens Intellectual Property Law - Hatch-Waxman Litigation

For more than a decade, we have represented some of the world’s largest and most successful generic pharmaceutical companies. In that time, we have successfully helped companies bring generic versions of many of the world’s best-selling and well-known drugs to market, and to monetize their pharmaceutical opportunities. Our services span every aspect of pharmaceutical-related intellectual property, including strategic counseling, litigation under the Hatch-Waxman Act, settlement, pre-suit analysis and Paragraph IV letters, and opinion letters. We have multiple litigators who have first chaired trials and appeals for several key drugs. We also have represented companies holding first-to-file status on several of the world’s best-selling drugs. Our trial teams are supported by several attorneys who hold advanced degrees in chemical sciences. We also have attorneys who have served in key positions at leading pharmaceutical firms, giving us a solid understanding of critical business issues facing our pharmaceutical clients.